Funds with similar focus
Fund Name | Location |
American Heart Association | Dallas, Texas, United States |
BW Ventures | Eindhoven, Noord-Brabant, The Netherlands |
China Capital | China, Guangdong, Shenzhen |
Coldstream | Bellevue, United States, Washington |
Galaxy Dingfa Investment | - |
Genentech | California, South San Francisco, United States |
Hessen Kapital I GmbH | - |
Hunan Xianghui Asset Management | China, Fujian, Hunan |
Inflect Health | California, Emeryville, United States |
MBM Capital Partners | England, London, United Kingdom |
Ministerio de Economia y Competitividad | Community of Madrid, Madrid, Spain |
Mytech | China, Shanghai |
On Command Corporation | Colorado, Denver, United States |
Signal Hill Equity Partners | Canada, Ontario, Toronto |
Songhyun Investment | - |
Starlight Ventures | Florida, Miami, United States |
Unisedu | Beijing, China, Haidian |
Vatel Capital | France, Ile-de-France, Paris |
Wavebreak International | Australia, Oxenford, Queensland |
Zijing Capital | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Altay Therapeutics | 23 May 2022 | San Francisco, California, United States | |||
Chameleon Biosciences | $11M | 25 Mar 2021 | California, United States | ||
DTx Pharma | $100M | 01 Mar 2021 | San Diego, California, United States | ||
Totient | $10M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
EpiBone | 07 Sep 2018 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Altay Therapeutics | 23 May 2022 | San Francisco, California, United States | |||
Chameleon Biosciences | $11M | 25 Mar 2021 | California, United States | ||
DTx Pharma | $100M | 01 Mar 2021 | San Diego, California, United States | ||
Totient | $10M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
TARA Biosystems | $10M | 23 Jun 2020 | New York, New York, United States | ||
EpiBone | 07 Sep 2018 | New York, New York, United States |